Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Unterluggauer Julia Judith |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2020
Originalarbeit (Zeitschrift)
** Roetzer, T; Furtner, J; Gesperger, J; Seebrecht, L; Bandke, D; Brada, M; Brandner-Kokalj, T; Grams, A; Haybaeck, J; Kitzwoegerer, M; Leber, SL; Marhold, F; Moser, P; Sherif, C; Trenkler, J; Unterluggauer, J; Weis, S; Wuertz, F; Hainfellner, JA; Langs, G; Nenning, KH; Woehrer, A
Sex-Specific Differences in Primary CNS Lymphoma.
Cancers (Basel). 2020; 12(6):
Doi: 10.3390/cancers12061593
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korrektur
** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J
Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268].
Transl Oncol. 2020; 13(2):490-492
Doi: 10.1016/j.tranon.2019.08.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Originalarbeit (Zeitschrift)
** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268
Doi: 10.1016/j.tranon.2018.10.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Neuhauser, M; Roetzer, T; Oberndorfer, S; Kitzwoegerer, M; Payer, F; Unterluggauer, JJ; Haybaeck, J; Stockhammer, G; Iglseder, S; Moser, P; Thomé, C; Stultschnig, M; Wuertz, F; Brandner-Kokalj, T; Weis, S; Bandke, D; Pichler, J; Hutterer, M; Krenosz, KJ; Boehm, A; Mayrbaeurl, B; Hager-Seifert, A; Kaufmann, H; Dumser, M; Reiner-Concin, A; Hoenigschnabl, S; Kleindienst, W; Hoffermann, M; Dieckmann, K; Kiesel, B; Widhalm, G; Marosi, C; Jaeger, U; Hainfellner, A; Hackl, M; Hainfellner, JA; Preusser, M; Woehrer, A
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Acta Oncol. 2019; 49(11):1-10
Doi: 10.1080/0284186X.2019.1599137
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rössler, I; Embacher, J; Pillet, B; Murat, G; Liesinger, L; Hafner, J; Unterluggauer, JJ; Birner-Gruenberger, R; Kressler, D; Pertschy, B
Tsr4 and Nap1, two novel members of the ribosomal protein chaperOME.
Nucleic Acids Res. 2019; 47(13):6984-7002
Doi: 10.1093/nar/gkz317
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A
Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82.
[Poster]
Web of Science
2018
Originalarbeit (Zeitschrift)
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528
Doi: 10.1038/s41598-018-32972-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Qiu, X; Xu, JY; Guo, JJ; Yahia-Ammar, A; Kapetanakis, NI; Duroux-Richard, I; Unterluggauer, JJ; Golob-Schwarzl, N; Regeard, C; Uzan, C; Gouy, S; Dubow, M; Haybaeck, J; Apparailly, F; Busson, P; Hildebrandt, N
Advanced microRNA-based cancer diagnostics using amplified time-gated FRET
CHEM SCI. 2018; 9(42): 8046-8055.
Doi: 10.1039/c8sc03121e
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kurzbericht/Letter
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79.
Doi: 10.1038/s41408-018-0112-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Zeitschrift)
** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science